Lars Ekman
Board Member
Ultragenyx Pharmaceutical Inc. (RARE)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Lars Ekman
Lars Ekman is recorded as Board Member at Ultragenyx Pharmaceutical Inc. (RARE). Amarin Corp Plc\Uk reported in an 8-K filed October 21, 2022 that Lars Ekman retired as director, effective December 31, 2022.
“In addition, on October 20, 2022, the Company announced that Lars Ekman and Patrick J. O’Sullivan will retire from the Board, effective as of December 31, 2022.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Ultragenyx Pharmaceutical Inc.
Other people whose current roles at this company are on record from its filings.
- Emil D. Kakkis CEO, Board Member
- Emil Kakkis CEO, Board Member
- Howard Horn CFO
- Eric Crombez, M.D. CTO
- Karah Parschauer General Counsel
- Amrit Ray, M.D. Board Member
- Clay B. Siegall Board Member
- Continuing Directors Board Member
- Corazon (Corsee) D. Sanders, Ph.D. Board Member
- Corsee Sanders, Ph.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.